Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 338 KB, PDF document
Post-transplant lymphoproliferative disease (PTLD) is a well-recognized complication after transplant. This study aimed to develop and validate a risk score to predict PTLD among solid organ transplant (SOT) recipients. Poisson regression identified predictors of PTLD with the best fitting model selected for the risk score. The derivation cohort consisted of 2546 SOT recipients transpanted at Rigshospitalet, Copenhagen between 2004 and 2019; 57 developed PTLD. Predictors of PTLD were high-risk pre-transplant Epstein–Barr Virus (EBV), IgG donor/recipient serostatus, and current positive plasma EBV DNA, abnormal hemoglobin and C-reactive protein levels. Individuals in the high-risk group had almost 7 times higher incidence of PTLD (incidence rate ratio (IRR) 6.75; 95% CI: 4.00– 11.41) compared to the low-risk group. In the validation cohort of 1611 SOT recipients from the University Hospital of Zürich, 24 developed PTLD. A similar 7 times higher risk of PTLD was observed in the high-risk group compared to the low-risk group (IRR 7.17, 95% CI: 3.05–16.82). The discriminatory ability was also similar in derivation (Harrell’s C-statistic of 0.82 95% CI (0.76–0.88) and validation (0.82, 95% CI:0.72–0.92) cohorts. The risk score had a good discriminatory ability in both cohorts and helped to identify patients with higher risk of developing PTLD.
Original language | English |
---|---|
Article number | 3279 |
Journal | Cancers |
Volume | 14 |
Issue number | 13 |
Number of pages | 13 |
ISSN | 2072-6694 |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
Funding Information:
Funding: This study was supported by Danish National Research Foundation (grant number 126) and by the Swiss National Science Foundation (grant number 148512), Unimedsuisse, and the Transplant Centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- EBV DNA, PTLD, SOT, transplantation
Research areas
ID: 326735085